Operator
Good morning, and welcome to the Oxford Biomedica plc Investor Presentation. [Operator Instructions] Before we begin, we’d like to submit the following poll.
I’d now like to hand over to the Oxford Biomedica plc team. Good morning.
Frank Mathias
CEO & Director
Good morning, everyone. I’m Frank Mathias, CEO of the company. So thank you all of you for joining us today in this investor presentation, which is, I have to say, the first on this platform. So I’m joined by our Chief Financial Officer, Dr. Lucy Crabtree; and we have also with us our Chief Business Officer, Dr. Sebastien Ribault.
I’m really delighted to present to you today, and we will be discussing our interim results for the first half of 2026. So I’m aware that probably at least some of you have seen our full briefing earlier this week, it was on Tuesday. So we will just provide you with a more short presentation, but this gives us more opportunity to be able to answer all your questions.
So if you want to look for the full briefing, you can watch out on our website. If I can go to the next slide. This is — yes, please consider the disclaimer as always, this is my next slide. We didn’t show that on Tuesday. That’s for those of you that might be less familiar, I wanted to start to show you a slide to make it clear what our company, OXB is doing and the crucial role we play in delivering life-changing therapies to patients.
So this
Credit: Source link
